Heparanase-1 (HPSE) plays a pivotal role in structural remodeling of the ECM and the glycocalyx, thus conferring protumorigenic, proangiogenic and prometastatic properties to many cancer entities. In addition to its extracellular function, recent studies suggest an intracellular activity of HPSE with a largely unknown significance during tumor progression. Therefore, we investigated the relevance of the dual functions of HPSE to malignant melanoma in vitro, as well as in different mouse melanoma models based on the intradermal or intravenous injection of melanoma cells. Consistent with its extracellular action, an HPSE deficiency led to a reduced shedding of the glycocalyx accompanied by a reduced availability of vascular endothelial growth factor, affecting tumor growth and vascularization. In contrast, we measured an elevated expression of the protumorigenic factors pentraxin-3, tissue factor, TNF-α and most prominently, MMP-9, upon HPSE knockdown. In vivo, an HPSE deficiency was related to increased lymph node metastasis. Since the inhibition of its extracellular function with heparin was unable to block the gene regulatory impact of HPSE, we proposed an intracellular mechanism. Immunostaining revealed a counter-staining of HPSE and NF-κB in the nucleus, suggesting a close relationship between both proteins. This finding was further supported by the discovery of a direct chargedriven molecular interaction between HPSE and DNA by using atomic force microscopy and a co-precipitation approach. Our findings are novel and point towards a dual function for HPSE in malignant melanoma with a protumorigenic extracellular activity and a tumor-suppressive nuclear action. The identification of molecular strategies to shuttle extracellular HPSE into the nuclei of cancer cells could provide new therapeutic options.
INTRODUCTION
As the only known enzyme capable to degrade heparan sulfate, heparanase-1 (HPSE) mediates the release of heparan sulfate-bound growth factors (such as, vascular endothelial growth factor (VEGF)) to promote endothelial cell activation and angiogenic responses. 1, 2 In addition to its extracellular action, HPSE has been discovered to exert nuclear action by shedding syndecan-1 in the nuclei of myeloma cells. 3 Loss of nuclear syndecan-1 interferes with gene transcription through enhanced histone acetylation and enhanced extracellular signal-regulated kinase activation, which includes the upregulation of matrix metalloproteinase 9 (MMP-9).
3-5 MMP-9 is known to be transcriptionally regulated by the NF-κB signaling pathway. 6, 7 Notably, other reports suggest a connection between HPSE and the regulation of NF-κB-related genes. [8] [9] [10] In addition to its enzymatic functions, the non-enzymatic activity of HPSE enhances Akt signaling, stimulates phosphatidylinositol 3-kinase (PI3K)-dependent migration and invasion of endothelial cells 11 and upregulates the expression of VEGF in several tumor cell lines via the Src pathway. 12 These findings suggest that the capacity of HPSE in regulating cell signaling and gene transcription depends on both its enzymatic and non-enzymatic activities as well as on its extracellular and/or intracellular localization.
Overexpression of HPSE exerts protumorigenic properties at the early stages of tumor initiation and facilitates tumor growth, angiogenesis and metastasis in many human cancer entities. [13] [14] [15] By cooperating with a Ras mutation, HPSE was shown to promote the development of skin malignancy. 15 However, in relation to the cytosolic HPSE, an increased amount of nuclear HPSE is associated with a decreased tumor growth and an increased survival of patients suffering from head and neck tumors. 16 This finding appears to be counterintuitive to the accepted pro-malignant action of HPSE and demonstrates a significant impact of nuclear HPSE on the progressivity of cancer cells. Although recent data consistently demonstrate reduced invasive properties upon HPSE downregulation in melanoma cells, [17] [18] [19] the contribution and underlying molecular mechanisms of nuclear HPSE in human malignant melanoma remains unexplored. Therefore, the present study aims to investigate the impact of HPSE, in particular its nuclear activity, on the malignant behavior of melanoma.
To investigate the regulatory mechanisms of HPSE in tumor progression of malignant melanoma, we evaluated the invasive properties of several melanoma cell lines in vitro as well as in vivo. The invasive properties of melanoma cells were related to the regulation of VEGF, MMPs and the NF-κB signaling pathway. cells expressed high levels of HPSE whereas comparable lower amounts of HPSE were produced by IGR37 cells, which were therefore used as a control cell line ( Figure 1a) . To investigate the cell-specific function of HPSE, we additionally attenuated HPSE expression by applying HPSE-specific siRNA (siHPSE). Knockdown efficiency assessed by immunoblotting and quantitative real-time PCR (RT-qPCR) was approximately~70% in comparison with cells transfected with non-targeting control siRNA (siCon) (Figures 1a-c) . To evaluate the progression of human malignant melanoma cells, we applied a previously established electrophysiological invasion assay. [22] [23] [24] The assay is based on the tumor cellinduced breakdown of an electrically tight epithelium, recorded by measurements of trans-epithelial electrical resistance (TEER) where low TEER value corresponds to a high invasive potential. The physical separation of the invading cells and the epithelium limits the system variables to secreted factors (schematic sketch in Figure 1d ). In comparison with the siCon group, knockdown of HPSE in BLM and MV3 cells resulted in a delayed TEER breakdown. No significant differences were measured in the control cell line IGR37 (Figure 1e ). Time courses of TEER experiments have been summarized as bar diagrams and are displayed in Figure 1f . The TEER data suggest a role for HPSE in the invasive capacity of human malignant melanoma. However, invasion was only delayed but not completely abolished, suggesting the contribution of other secreted factors that compensate the absence of HPSE.
Knockdown of HPSE enhances the expression of MMP but reduces the availability of VEGF We previously demonstrated that MMP-2 and MMP-9 secreted from melanoma cells are strongly involved in the breakdown of TEER. 23, 24 Therefore, we analyzed the secreted amounts of both proteinases in the supernatants of the melanoma cells by gelatin gel zymography. Figures 2a and b show a dramatically increased RT-qPCR analysis of MMP-9 (e) and MMP-2 (f) gene expression of melanoma cells by siRNA transfection. White bar: siCon transfected; black bar: siHPSE transfected. *P o0.05; **P o0.01; NS: no significant difference. (g) VEGF ELISA analysis of cell supernatants harvested from transfected human melanoma cells. White bar: siCon transfected; black bar: siHPSE transfected. NS: no significant difference; **P o0.01. (h) Immunofluorescence stainings of transfected human melanoma cells. VEGF was stained in green and the glycocalyx was stained in red using fluorophore-conjugated wheat germ agglutinin (WGA). Scale bar corresponds to 20 μm. MMP-9 activity in the supernatants of HPSE-deficient BLM and MV3 cells. In contrast, MMP-2 activity was not affected in both cell lines (Figures 2c and d) . No MMP-9 activity and only a slightly decreased MMP-2 activity were detected in the control cell line IGR37 after HPSE silencing (Figures 2a, c and d) . To demonstrate whether the increased amounts of MMP-9 found in the supernatants of BLM and MV3 cells were related to an elevated gene expression level we performed RT-qPCR. In accordance with our gel zymography data, we found a strongly increased MMP-9 expression in HPSE-deficient BLM and MV3 cells (Figure 2e) . Notably, these cells also showed an increased expression of MMP-2 which could not be detected by gelatin gel zymography. Expression levels of neither MMP-9 nor MMP-2 were affected in IGR37 cells upon HPSE knockdown (Figures 2e and f) .
HPSE is known to release the surface-bound VEGF by shedding the cellular glycocalyx as well as the ECM. 1 Recently, we demonstrated that VEGF availability is also related to the extracellular activity of MMP-9 and MMP-2. 20, 25 Also, in the present experimental model, we found that the concentration of VEGF was significantly attenuated in the supernatants of BLM and MV3 siHPSE cells (Figure 2g ). No significant difference was found in IGR37 cells (Figure 2g ). Consistent with a decreased amount of VEGF in the supernatants, we detected an increased retention of VEGF within the glycocalyx of BLM and MV3 cells, as revealed by immunostaining (Figure 2h ). Although a slight decrease in VEGF mRNA levels was found in BLM siHPSE cells, VEGF expression levels were not affected in MV3 or IGR37 cells (Supplementary Figure S1A) . These data suggest that the regulative impact of HPSE on VEGF in melanoma cells is mostly related to the extracellular activity of HPSE, which in turn leads to a reduced availability of VEGF upon HPSE deficiency.
To determine whether the upregulation of MMPs in human melanoma cells after HPSE knockdown was directly related to the shedding of the ECM, we blocked the extracellular action of HPSE with unfractionated heparin. Heparin is known to inhibit the enzymatic activity of HPSE and to block VEGF. 26, 27 In contrast to HPSE silencing, unfractionated heparin treatment was not able to upregulate MMP-9 or MMP-2 in any of the three human melanoma cell lines (Supplementary Figures S1B and C) . Further control experiments excluded an expressional regulation of HPSE (Supplementary Figures S1D-F) .
Taken together, these data suggest a dual role for HPSE in human melanoma cells, consisting of both an intrinsic gene regulatory effect and an extracellular activity. Although the availability of VEGF in the supernatant depends mainly on the extracellular activity of HPSE, the upregulation of MMPs appears to be independent of the extracellular activity of HPSE and more related to an intrinsic regulation of gene expression.
HPSE is associated with the NF-κB signaling pathway The gelatinase MMP-9 is known to be transcriptionally regulated by NF-κB. 6, 7 Interestingly, HPSE has already been linked to NF-κB activation by the descriptive analysis of human tumor tissues. [8] [9] [10] These results promote us to hypothesize a potential molecular connection between HPSE and the NF-κB signaling pathway. To this end, we next analyzed whether HPSE alters the expression of other NF-κB-related genes. In comparison with the control cell line IGR37, RT-qPCR analysis revealed a significantly increased expression of TNF-α, tissue factor and pentraxin-3 (PTX-3) in BLM and MV3 cells upon HPSE knockdown (Figures 3a-c) . As NF-κB is transferred from the cytoplasm into the nucleus after activation, we further studied the distribution of the NF-κB subunit p65 by immunostaining and western blot analysis (Figures 3d and e) . Consistent with an elevated MMP-9 expression and other NF-κB-related genes, the knockdown of HPSE resulted in a significantly increased amount of nuclear NF-κB in BLM and MV3 cells, suggesting a molecular linkage between HPSE and NF-κB. Immunostaining of HPSE and MMP-9 were performed as control experiments, showing a reduced HPSE and increased MMP-9 staining in the HPSE downregulated cells (Supplementary Figures  S2A and B) . It is intriguing to note that HPSE localized mainly in the nuclei rather than in the cytoplasm of the human melanoma cells. We further performed control experiments with recombinant human TNF-α, a potent activator of the NF-κB signal transduction pathway. 28 Immunostaining and western blot analysis identified a translocalization of NF-κB from the cytoplasm to the cell nucleus upon TNF-α treatment ( Supplementary Figures S2C and D) . Similar to the HPSE knockdown experiments (Figure 2 ), the stimulation of BLM and MV3 cells with TNF-α (1, 5 and 10 ng/ml) also resulted in a dose-dependent increase in MMP-9 expression (Supplementary Figures S3A-C) . Interestingly, our data demonstrated a significantly decreased HPSE expression upon TNF-α treatment ( Supplementary Figures S3D-F) . Taken together, these data indicate a close relationship between HPSE and NF-κB.
Interaction between HPSE and DNA is not limited to the NF-κB specific binding sequence Because heparan sulfate, the natural substrate of HPSE, and DNA are both strongly negatively charged polyelectrolytes, we hypothesized a charge-driven interaction between HPSE and DNA in the cell nucleus that could potentially interfere with the NF-κB signaling pathway. To demonstrate this, we purified genomic DNA from melanoma cell nuclear extracts by ethanol precipitation. Corresponding western blot analysis indicated a coprecipitation of HPSE in low salt conditions (0.1 M NaCl) ( Figure 4a ). In contrast, HPSE was not detected after eluting DNA-bound proteins with a high amount of salt (5 M NaCl) prior to the precipitation (Figure 4a ). High amounts of salt are known to efficiently screen electrostatic forces, explaining the dissociation of DNA-bound HPSE.
The interaction between HPSE and DNA was further confirmed by atomic force microscopy by investigating the interaction of recombinant human HPSE with plasmid DNA. As shown in previous studies, a molecular interaction would be displayed by the formation of aggregates. 29 Representative images of single HPSE molecules ( Figure 4b ) and circular plasmid DNA (Figure 4c ) are shown. The co-incubation of HPSE and DNA at different molar ratios resulted in the formation of different protein-DNA complexes (Figures 4d and e). Although we partially visualized free DNA strands at low concentrations of HPSE (Figure 4d ), a saturated complex formation of DNA was apparent at high concentrations of HPSE ( Figure 4e ). In control experiments using bovine serum albumin (BSA) instead of HPSE, no significant interaction between BSA and DNA was found (Supplementary Figure S4) .
The assumed charge-driven interaction suggests that the binding between HPSE and DNA is not sequence-dependent. To further test this, we performed a solid-phase binding assay. For this purpose, the binding of biotin-tagged NF-κB-specific oligonucleotides or randomized oligonucleotides to surfaceimmobilized HPSE was analyzed. BSA was used as a negative control, whereas positively charged poly-L-lysine served as a positive control. Compared with BSA, the binding of oligonucleotides to HPSE was markedly increased, indicated by fourfold higher optical density values, confirming the interaction between HPSE and DNA (Figure 4f) . Notably, DNA binding was not strongly dependent on the sequence, as we could not measure a significant difference between the NF-κB-specific oligonucleotides and the randomized oligonucleotides (Figure 4f) .
Taken together, these data suggest that expressional regulation of MMPs and related factors is due to a direct interference at the gene transcriptional level by a nuclear HPSE-DNA interaction. As the binding capacity was not restricted to the NF-κB-specific binding sequence, other signaling pathways might also be involved.
Downregulation of HPSE inhibits tumor xenograft growth and angiogenesis but promotes lymph node metastasis formation Intradermal injection of stable siHPSE or siCon-transfected B16F10 cells (7.5 × 10 5 ) into the dorsal skin of C57BL/6 mice led to the formation of intact tumors with lymphatic tumor progression resembling the clinical situation of melanoma patients. The knockdown efficiency of HPSE was approximately~75% and cell viability was not affected (Supplementary Figures S5A and B) . The time-dependent tumor growth was followed for 30 days. Tumor xenografts produced by siHPSE cells displayed a slower growth rate compared with control xenografts (Figure 5a ). Previous reports, documenting the impact of HPSE on the malignancy of melanoma, were based on the intravenous injection of the tumor cells. 30 Therefore, we performed corresponding control experiments by injecting B16F10 melanoma cells into the tail veins of mice and assessed the distant lung metastasis. Consistent with the previously published literature, formation of lung metastatic foci was markedly reduced in mice receiving siHPSE cells (Supplementary Figure S5C) .
As our in vitro data demonstrated the involvement of HPSE extracellular activity in VEGF release from cell surface ECM, we hypothesized an enhanced immobilization of VEGF in the tumor tissue formed by HPSE knockdown cells. To test this, we immunostained VEGF in tumor sections, which did show an increased VEGF fluorescence intensity upon HPSE knockdown (Figure 5b) . To understand the impact of VEGF in our model, we analyzed the vessel density in tumors. Representative mosaic images of CD31-immunostained cryosections composed of 48 consecutive microscopic fields are presented in Figure 5c . Quantitative analysis of the average blood vessel amount of every single microscopic field in each group (a minimum of 12 mosaic images from six xenografts per group) revealed a twofold decrease in microvessel density in tumors produced by siHPSEtransfected cells versus siCon cells (Figure 5d ), suggesting a reduced availability of VEGF. 31 A previous report demonstrated that elevated levels of VEGF results in an abnormal and impaired functionality of tumor vessels. Correspondingly, the reduction of VEGF in tumor tissue, for example, by an anti-angiogenic therapy, is known to result in a normalization of the vasculature as indicated by an increased blood flow. 32 In accordance with this and indicative of a reduced availability of VEGF, we measured, by dynamic contrast-enhanced magnetic resonance imaging, an increased relative blood volume in tumors that were generated by HPSE-deficient B16F10 cells (Figure 5e ).
However, in contrast to a decreased tumor growth and an antiangiogenic effect, we observed a significant increase in lymph node metastasis (Figure 6a ). While four (57%) of the seven mice developed lymph node metastasis in the siCon group, the corresponding number of metastatic mice increased to six (86%) in the siHPSE group. Accordingly, our data showed a clear tendency of a reduced survival rate in mice bearing tumors of HPSE-deficient B16F10 cells (Figure 6b ). Because our in vitro data reflected that melanoma progression might be related to an increased NF-κB activation and expression of MMPs, we next performed gelatin-based in situ zymography to assess MMP activities in tumor tissues. Compared with the siCon group, tumors in the siHPSE group exhibited significantly higher MMP activities ( Figure 6c ). As in situ zymography was unable to distinguish between MMP-2 and MMP-9, we performed RT-qPCR on B16F10 cells. A 2.5 ± 0.4-fold increase in MMP-2 mRNA levels was found in the siHPSE-transfected cells compared with the control group (Figure 6d) .
To unify our in vivo model (mouse melanoma cell line) with our in vitro data (human melanoma cell lines), we performed additional experiments with ret transgenic mouse melanoma cells, as PCR results revealed a dramatic increase in MMP-9 mRNA levels in the HPSE knockdown cells (Supplementary Figure S6A) . Consistent with the data from the B16F10 tumors, ret siHPSE tumors represented a slower growth rate compared with control xenografts, together with an attenuated tumor angiogenesis (Supplementary Figures S6B-D) . Similarly, an increased amount of mice with metastatic lymph nodes was identified in the siHPSE group (Supplementary Figure S6E) .
Because our in vitro results point to the regulation of the NF-κB-related genes through the binding of DNA, we further investigated the effect of HPSE on NF-κB signaling in vivo, applying immunostaining of tumor tissue sections and a protein profiling of tumor tissue lysates. Although no significant differences in NF-κB nuclear translocalization were identified in the cryosections (Figure 6e) , we detected the upregulation of 20 NF-κB-dependent proteins in siHPSE tumor lysates, including RANTES, TNF-α and pro-MMP-9 (Supplementary Figure S6F) . It is worth mentioning that we also measured the downregulation of NF-κB-related proteins such as MMP-3 and MIP-2.
Taken together, these results demonstrate that HPSE knockdown inhibited tumor growth and angiogenesis involving the NF-κB signaling pathway and MMP activity, which support tumor progression and metastasis formation in vivo. A schematic model shown in Figure 7 summarizes the main results of our study.
DISCUSSION
Prometastatic activities of HPSE have been observed in several human malignancies, including colorectal carcinoma, cervical cancer and multiple myeloma. [33] [34] [35] However, the relevance of the more recently discovered gene regulatory functions of nuclear HPSE 4,5 remains uninvestigated in melanoma progression, which was the motivation behind our study.
The three human melanoma cell lines used in this study represent cells with different basic expression levels of HPSE, high in BLM and MV3 cells but low in IGR37 cells (Figure 1a) . Different cellular behaviors might be related to the different origins of the cancer cells. BLM cells were generated from a lung metastasis, whereas MV3 and IGR37 cell were previously isolated from lymph node metastases. [36] [37] [38] In the first set of experiments, we investigated the invasive properties of all three cell lines with an electrophysiological cell-based invasion assay previously established in our laboratory. [22] [23] [24] One of the key features of this assay is the high sensitivity for evaluating very early steps in invasion. 23 In contrast to IGR37 cells, we found that knockdown of HPSE attenuated the invasive properties in BLM and MV3 cells, as indicated by a delayed decrease in electrical resistance (Figure 1e) . Notably, TEER breakdown was only delayed but not completely abolished, suggesting the contribution of other secreted factors. As we previously demonstrated that MMPs may account for the invasive properties of melanoma cells in TEER breakdown, 23, 24 we further analyzed their impact within our experimental setting.
MMPs are deeply connected to physiological and pathophysiological processes related to extracellular matrix modification as it occurs during the spread of cancer cells. 39 As we have identified in previous studies that MMP-1, MMP-2, MMP-9 23, 40 and VEGF 20 are crucially involved in the progression of melanoma cells, we further analyzed the release and expression of MMPs and VEGF upon HPSE knockdown. Surprisingly, we found a strong upregulation of MMP-9 in BLM and MV3 cells upon HPSE knockdown, which might be the explanation for the delayed but not sustained TEER breakdown (Figures 2a and e ). An elevated enzymatic activity of HPSE has been reported to enhance MMP-9 expression in myeloma cells. 4, 5 In our case, to distinguish whether the expressional upregulation of MMPs is associated with the HPSEmediated shedding of the ECM and the related release of factors such as VEGF, we performed blocking studies with heparin. 26, 41 Because blockage of the extracellular activity of HPSE by heparin was not able to upregulate the expression of MMPs (Supplementary Figure S1B) , we conclude that the regulatory effect depended on the nuclear function of HPSE. Additionally and in accordance with literature, 12 ,42 the present study also documented a reduced availability of VEGF due to an impaired shedding of the ECM upon the downregulation of HPSE (Figures  2g and h ). These data clearly indicate a dual function of HPSE in human melanoma cells comprising an intrinsic gene regulatory effect as well as an extracellular activity.
The pathophysiological relevance of HPSE on VEGF and MMP regulation was further confirmed in our tumor tissues. The microvessel density was reduced in tumor sections, together with an attenuated VEGF availability, indicating that HPSE is highly involved in tumor angiogenesis, a pivotal step for tumor growth and spreading (Figures 5b-d) . Increased microvessel density was found to correlate with the upregulation of HPSE in the previous studies, which was attributed to the proangiogenic property of HPSE. 12, 35 Compared with the siCon group, siHPSEtransfected tumors exhibited significantly enhanced MMP activities (Figure 6c) . Intriguingly, HPSE knockout mice were reported to exhibit elevated expression of MMP family members such as MMP-2, MMP-9 and MMP-14 in an organ-dependent manner, suggesting a type of compensation for HPSE deficiency. 43 Although HPSE deficiency was associated with an impaired primary tumor growth, our data showed an increased rate of lymph node metastasis together with a tendency of decreased survival (Figures 6a and b) . However, we also found a marked reduction of lung metastatic foci in mice receiving siHPSE cells via an intravenous injection (Supplementary Figure S5C) , consistent with the published data. 30 The complexity in terms of regulation and function prevents a straightforward interpretation of experimental results. It may suggest that a different molecular mechanism affecting tumor metastasis formation may be involved in our intradermal animal model, mainly depending on a change of the local tumor microenvironment. Interestingly, we identified an increased amount of TNF-α, IL-1α, IL-2 and RANTES in tumor tissues upon HPSE knockdown (Supplementary Figure S6F) . Those proteins are known as strong indicators of inflammation, which might explain the impaired survival of mice bearing siHPSE tumors (Figure 6b) . Accordingly, our recent data suggest that IL-1 mediates a marked production of IL-6, which correlates with poor prognosis for patients suffering from malignant melanoma. 44 Moreover, high levels of RANTES were demonstrated to be associated with poor outcome. 45, 46 MMP-9 expression is transcriptionally regulated through the activation of the NF-κB signal transduction pathway.
6,7 NF-κB was perviously identified as a crucial factor for vascular dissemination of melanoma and decisive for the survial of the affected human patients. 47 Moreover, it has been reported that NF-κB activation upregulates HPSE expression in several tumors.
8-10 Therefore, we further investigated the relationship between HPSE and NF-κB in melanoma cells. Knockdown of HPSE significantly induced the expression of TNF-α, tissue factor and PTX-3, all known as NF-κB-related products. [48] [49] [50] In addition, immunostaining and western blot analysis revealed an increased amount of nuclear NF-κB upon HPSE knockdown in human malignant melanoma cells. These data strongly suggest a close relationship between HPSE and NF-κB. Recently, one study focusing on the regulatory relationship between HPSE and NF-κB in glioblastoma cells questioned this connection. 51 However, progression of glioblastoma is not associated with metastasis formation which is indicative for a different contribution of the NF-κB signaling. In the present study, we detected that HPSE expression was inhibited upon the activation of NF-κB by exogenous TNF-α stimulation in human melanoma cells (Supplementary Figures S3D-F) . This further confirms the mechanistic connection between HPSE and NF-κB. HPSE has been shown to colocalize with nuclear heparan sulfate in the nucleus of cancer cells. 3, 52, 53 Our data could also clearly demonstrate the nuclear localization of HPSE in melanoma cells (Supplementary Figure S2A) . We hypothesized a direct interaction between HPSE and DNA, which may explain the interference with the NF-κB pathway. The direct interaction of HPSE with DNA was speculated earlier 53 and has now been proven for the first time by high-resolution atomic force microscopy (Figures 4b-e) and the co-precipitation of HPSE with genomic DNA (Figure 4a) . We provided further evidence that the interaction between HPSE and DNA is not restricted to a specific DNA sequence, which potentiates the interference with other gene transcriptional pathways next to the NF-κB-dependent signaling (Figure 4f) .
The mechanisms described here emphasize a close connection between HPSE, MMPs and VEGF. Owing to a high degree of complexity, the putative relevance and/or crucial contribution of each described pathway in patients is not yet predictable. In conclusion, our data illustrate the duality of HPSE function ( Figure 7 ). While nuclear HPSE interfered with the regulation of gene transcription by interaction with DNA, shedding of the ECM is related to the release of VEGF, thereby modulating the vessel formation in the tumor. As a consequence, any potential benefit to the patient is likely dependent on the tumor cell-specific behavior and the associated ratio between VEGF availability and expressional regulation of pro-metastatic factors such as MMPs. These findings are novel and contribute to a more comprehensive understanding of HPSE in relation to protein expression and tumor cell progression, thus providing new insights into therapeutic strategies. Guided also by the clinical observation of a tumor-suppressive function of nuclear HPSE in head and neck cancers, 16 we propose the delivery of HPSE into the nuclei of melanoma cells, in combination with an inhibition of its extracellular activity, may represent the most beneficial therapeutic concept.
MATERIALS AND METHODS

Antibodies and reagents
Polyclonal rabbit anti-human HPA1 (sc-25825) and monoclonal mouse anti-human NF-κB p65 (sc-8008) antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Monoclonal mouse anti-β-actin antibodies were purchased from Sigma-Aldrich (Saint Louis, MO, USA). Monoclonal mouse anti-human HPSE-1 antibodies (mAb 130) were purchased from Insight Biopharmaceuticals Ltd. (Rehovot, Israel). Polyclonal rabbit anti-human VEGF antibodies were purchased from Cell Sciences (Canton, MA, USA). Polyclonal rabbit anti-mouse VEGF antibodies were purchased from Santa Cruz Biotechnology. Monoclonal rat anti-mouse CD31 antibodies were purchased from BD Pharmingen (BD Biosciences, Heidelberg, Germany). Unfractionated heparin and recombinant human tumor necrosis factor-α (TNF-α) was purchased from Merck (Merck KGaA, Darmstadt, Germany).
Cell culture
The human metastatic melanoma cell lines BLM, MV3 and IGR37 have been described previously [36] [37] [38] and were cultured in RPMI 1640 or Dulbecco's modified eagle medium (PAA, Pasching, Austria) supplemented with 10% fetal calf serum, 1% L-glutamine and 1% penicillin/streptomycin. Mouse B16F10 melanoma cells and melanoma cells from ret transgenic mice 54, 55 were cultured in DMEM or RPMI 1640 medium supplemented with 10% fetal calf serum and 1% L-glutamine. The high-resistance C7 subclone of Madin-Darby canine kidney cells (MDCK-C7) 56 were cultured in supplemented MEM medium (PAA). All cells were cultured at 37°C in a humidified 5% CO 2 /95% air atmosphere. Transfections were performed as previously described. 20 TEER measurements were performed with MDCK-C7 cells as reported earlier. 22 
Enzyme-linked immunosorbent assay
Released VEGF in melanoma cell supernatants was measured by a sandwich enzyme-linked immunosorbent assay (ELISA) technique following the manufacturer's protocol provided by DuoSet ELISA Development Kit (R&D, Minneapolis, MN, USA) as previously described. 20 In vivo experiments Mouse B16F10 or ret transgenic melanoma cells transfected with control siRNA or siHPSE vectors (pRNAT-CMV3.1-Neo, GenScript USA Inc., Piscataway, NJ, USA) were inoculated as cell suspension (7.5 × 10 5 cells/ 100 μl PBS) intradermally to the dorsal skin of 10-week-old female C57BL/6 mice (n = 7). Xenograft sizes were determined every 2 days using a caliper. Tumor volume (V) was calculated with V = 0.5LW 2 , where L is the length and W the width of the xenograft. After 4 weeks, the mice were killed, and the xenografts were resected, weighed and fixed in Tissue-Tek (Sakura Finetek, Staufen, Germany) for cryosectioning. Lymph nodes (inguinal, axillary and mandibular) were collected, and macroscopic pictures were taken. Metastatic lymph nodes were identified by melanin produced by melanoma cells.
For the analysis of lung metastasis formation, mice were intravenously injected with B16F10 cells (1.5 × 10 5 ) and killed after 14 days as previously described. 30 Metastatic foci were counted, and macroscopic pictures of lungs were taken. Statistical analysis was performed using the Mann-Whitney test.
Magnetic resonance images were acquired on a 1.5 T clinical magnetic resonance scanner (Symphony, Siemens Healthcare Diagnostics GmbH, Erlangen, Germany) using a home-built coil for radiofrequency excitation and detection, designed as a cylindrical volume resonator. Data from the dynamic contrast-enhanced magnetic resonance imaging were analyzed according to a pharmacokinetic two-compartment model, 57 using the Dynalab workstation (Fraunhofer Mevis, Bremen, Germany) to calculate amplitude A ((arbitrary units), associated with the relative blood volume). 58 Immunofluorescence staining, western blot and zymography Immunofluorescence staining, western blot, gelatin gel zymography and in situ zymography were performed as previously described. 20, 21, 25 Proteome profiler array
The Proteome Profiler Array was performed using the Mouse Cytokine Array C1000 kit (RayBiotech, Norcross, GA, USA) to measure the relative levels of proteins in melanoma tissue lysates. The assay was performed according to the manufacturer's instructions. Melanoma tissue lysates were prepared as previously described. 25 Tissue lysates were pooled and equal amounts of total protein (500 μg) were loaded onto the array kit. Blot images were analyzed with ImageJ software. Figure 7 . Schematic model of the current study. The cytoplastic HPSE are released to the extracellular space and exert the enzymatic activity to shed the the heparan sulfate of the ECM. The heparan sulfate-bound cytokines and molecules including VEGF get released and promote tumor vascularization and thus growth of tumor. As an inhibitor of HPSE, heparin can partially inhibit this effect. The nuclear HPSE inhibits action of transcription factors (e.g., NF-κB) by competing for the binding to DNA thus preventing downstream genes expression, such as MMP-9. MMPs are ECM-degrading enzymes which facilitate tumor cell extravasation as well as intravasation and thus enhance metastasis formation.
Solid-phase oligonucleotide binding assay
Binding assays were performed in a 96-well plate (MaxiSorp, NuncTM, Thermo Fisher Scientific, Schwerte, Germany). Wells were coated with HPSE, BSA or poly-L-lysine (1 ng/well) and subsequently incubated with biotinylated oligonucleotides (20 fmol/well) in incubation buffer (100 mM Tris, pH 7.5, 100 mM NaCl, 2 mM MgCl 2 ). Non-bound oligonucleotides were removed with incubation buffer. Prior to the colorimetric detection of biotin residues by horseradish-peroxidase-conjugated streptavidin, the wells were blocked with 1% BSA in incubation buffer.
RNA Isolation and RT-qPCR
Total RNA was extracted with the RNeasy mini kit (Qiagen, Hilden, Germany). RT-qPCR was performed as previously described. 20 The PCR primer sets were designed as follows: Human HPSE Forward (5′-TGGGTT CTCCAAAGCTTC-3′) and Reverse (5′-TTGATTCCTTCTTGGGATCG-3′); Human TNF-α Forward (5′-CCCCAGGGACCTCTCTCTAATC-3′) and Reverse (5′-GCT TGAGGGTTTGCTACAACATG-3′); Human β-actin Forward (5′-AGAAAATCT GGCACCACACC-3′) and Reverse (5′-CCATCTCTTGCTCGAAGTCC-3′); Mouse HPSE Forward (5′-GGTGGAACAGCTCCAACGCCC-3′) and Reverse (5′-CCC TCGAGGCTGACCGATGT-3′); Mouse VEGF-A Forward (5′-GAAGGGAG AGGAGCCCGCCA-3′) and Reverse (5′-CGCATCAGCGGCACACAGGA-3′); Mouse MMP-2 Forward (5′-TGAGCTGTGGACCCTGGGAGA-3′) and Reverse (5′-GTGGTGCCACACCAGCGGTAG-3′); Mouse MMP-9 Forward (5′-CGAGTT GTGGTCGCTGGGCA-3′) and Reverse (5′-CCCAACTACGGTCGCGTCCAC-3′). The primer sets for human tissue factor, VEGF-A, MMP-2, MMP-9, pentraxin-3 (PTX-3) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were purchased from the Qiagen company (QuantiTect primer assay, Qiagen).
Atomic force microscopy
Recombinant HPSE (R&D systems, Minneapolis, MN, USA) was mixed at different molar ratios with DNA and incubated for 30 min at room temperature in buffer (25 mM Tris/HCl, 150 mM NaCl, 5 mM CaCl 2 , 5 mM MgCl 2, pH 7.4). Then, 2 μl of the HPSE-DNA complex solution was adsorbed to freshly cleaved mica for 1 min. The surface was rinsed with 1 ml of ultrapure water and imaged by atomic force microscope (Nanowizard I, JPK instruments, Berlin, Germany). Images were taken in tapping mode at a frequency of 315 Hz, applying a cantilever with a spring constant of 14 N/m (NSC35, Micromash, Tallinn, Estonia).
Statistical analysis
All results are representative of at least three independent experiments. The data are expressed as the mean ± s.d. Except for where noted, comparisons between two groups were analyzed by the two-tailed Student's t-test, and Po 0.05 was considered as statistically significant.
